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Abstract Background Iron (Fe) defi-
ciency is a known feature of cyanotic 
congenital heart disease (CCHD) and 
may worsen symptoms. The preva-
lence of iron deficiency among chil-
dren with CCHD at the University 
College Hospital (UCH), Ibadan is 
unknown. Erythrocyte indices of iron 
status are easier and less expensive to 
determine than serum iron, serum 
ferritin and total iron binding capac-
ity, which are the standard tests of 
iron deficiency.  
Objectives: To examine the erythro-
cyte indices of iron status in children 
with CCHD in UCH, and determine 
the prevalence of iron deficiency 
among such patients, by comparing 
the values obtained with established 
reference values. 
Subjects and Methods: The packed 
cell volume (PCV), haemoglobin 
(Hb), mean corpuscular volume 
(MCV), mean corpuscular haemoglo-
bin concentration (MCHC) and red 
cell distribution width (RDW) of 40 
children with CCHD, determined 
using a Sysmex 1000X1 Coulter 
counter, were compared with stan-
dard reference values. 
Results: Mean+SD values obtained 
were – PCV: 58.6+11.6%. MCV: 
80.7+12.1 µm3, MCH: 25.9+9.5g/
dl, MCHC: 30.9+4.1 and RDW: 
20.5.5+12.6%. 
 Lower-than-normal values for 
MCV, MCH and MCHC were 
found in 33.5%, 42.5% and 72.5% 
of patients, respectively, while 
77.5% had higher-than-normal val-
ues for RDW. However, using the 
criteria based on a combination of 
RDW and MCV, 35% of patients 
were iron deficient. 
Conclusion: A large proportion of 
Nigerian children with CCHD ap-
pear to be iron deficient and are 
therefore likely to benefit from rou-
tine iron therapy. 
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Fallot’s tetralogy is the commonest cyanotic congenital 
heart disease (CCHD) worldwide. It is characterised by 
cyanosis of variable severity, associated with sympto s 
such as decreased effort tolerance, squatting, hyper-
cyanotic spells, and in severely polycythaemic patients, 
bleeding diatheses and cerebrovascular events. Iron (Fe) 
deficiency is known to be a feature of CCHD1, 2 and may 
worsen symptoms. Iron therapy is therefore recom-
mended for those who demonstrate this feature. The iron 
status of children with CCHD seen at the University 
College Hospital (UCH), Ibadan, has never been stud-
ied. Iron therapy is not routinely administered to such 
children at the UCH. Many are extremely polycythae-
mic, by virtue of either the severity, or the chronicity of 
their hypoxia, together with the fact that the time inter-
val between diagnosis and surgery, whether palliative or 
definitive, is often prolonged for logistic or technical 
reasons. Iron therapy might benefit some of these pa-
tients, particularly those in whom delays between diag-
nosis and surgery may be inevitable because of other 
contingencies. A study of the iron status of children with 
CCHD was therefore thought to be germane, in that re-
sults of the study would stimulate the formulation f 
guidelines as to the need or otherwise for iron therapy in 
patients with CCHD in general, and Fallot’s tetralogy in 
particular. 
 
Although determination of serum iron, serum ferritin 
and total iron binding capacity are the standard tests of 
iron deficiency, they are expensive and not routinely 
available. We therefore decided to use erythrocyte indi-




The study aimed to: 
1. Examine the erythrocyte indices of iron status in 
children with CCHD in UCH,                            
2. Determine the prevalence of iron deficiency among 
such patients, by comparing the values obtained in 




Materials and methods 
 
Forty patients of the Paediatric Cardiology Unit of the 
UCH, Ibadan with a diagnosis of CCHD whose haema-
tological data were complete were recruited into the
study. Each patient had undergone a thorough clinica  
evaluation with special reference to the cardiovascular 
system (CVS), along with chest radiography, electroca -
diography and 2-dimensional (2-D) echocardiography, 
in order to establish the specific diagnosis. Their packed 
cell volume (PCV), haemoglobin (Hb), mean corpuscu-
lar volume (MCV), mean corpuscular haemoglobin con-
centration (MCHC) and red cell distribution width 
(RDW) were determined using a a Sysmex 1000XI  
Coulter counter. Each patient’s Hb genotype was also
determined.  Normal reference ranges for each parame-
ter were obtained from table 1, (adapted from  Pesce.3)
Patients were adjudged to be iron deficient according to 
criteria combining the use of `MCV and RDW, ie if both 
the MCV was lower than normal, and RDW was higher 
than normal for the age4. 
 




The data were entered into an Excel spread-sheet. and 
analysed using SPSS 17.0 for Windows (SPSS Inc., Chi-
cago, USA, 2010). Ranges, means and standard devia-
tions were computed and compared with standard refer-
ence values using the Students t test. The level of sig-





There were 23 males and 17 females and their ages 
ranged from 1 to 162 (median = 48) months. Table 2 
shows that the mean ages and weights of the males did not 
differ significantly from those of the females. 
Age 1-
14days 
>14days >28days – 
5years 
>5years 
Haematocrit (%) 48–65 28–42 35–45 35–45 
Haemoglogbin (g) 14.5–
22.5 
9.0–14.0 11.5–15.5 11.5–15.5 
Mean corpuscular volume 
(µ m3) 
95–121 70–86 70–86 77–95 
Mean corpuscular haemo-
globin  (pg/cell) 
  
28–40 28–40 24–30 25–33 
Mean corpuscular haemo-
globin concentration (g/dl) 
  
28–38 29–37 30–36 31–37 
Red cell distribution width 
(%) 
11 - 14.0 11- 14.0 11 - 14.0 11 - 14.0 
Table 2: Mean age and weight of study patients 
Fallot’s tetralogy formed the majority - 36 (90 %) of the 
patients, followed by Tricuspid atresia (TA) - 3 
(7.5%).and Transposition of the Great Arteries (TGA) - 
1 (2.5%). 
The patients’ haematological profiles are depicted in 
Table 3  
 
Table 3: Haematological profile of study patients  
Table 4 shows that the frequencies of patients with 
values suggestive of Fe deficiency in each parameter 
were: MCV 37.5%, MCH 42.5%, MCHC 72.5%, and 
RDW 77.5%.  
 
Table 4: Distribution of patients’ haematological parameters 
 
Figures in bold type represent the percentages of patients with values 
suggestive of iron deficiency 
 
However Table 5 shows that using the classification 
based on RDW and MCV by Bessman et al,4 which is 
the criterion adopted for this study, only 35% of the pa-
tients met the criteria for iron deficiency.  
 
Table 5:Distribution of patients by MCV and RDW (indices 
of iron deficiency) 
Using the classification based on RDW and MCV4from the above 
table 35.0% of the patients met the criteria for irn deficiency. 
  Male (23) Female (17) p 
Mean SD Mean SD 
Mean Age 
(months) 
67.5 46.4 54.3 43.9 0.402 
Mean weight (kg) 15.6 4.3 11.9 9.0 0.218S 
  Mean SD Median Mini-
mum 
Maximum 
Haematocrit (%) 58.6 11.6 59.0 29.0 85.0 
Haemoglobin (g) 17.0 4.0 16.9 7.2 22.9 
Mean corpuscular  
volume (µ m3) 
80.7 12.1 80.0 59.0 101.0 
Mean corpuscular 
haemoglobin  (pg/cell) 




30.9 4.1 29.9 26.4 45.6 
  Patients’ values 
Low Normal High 
N % N % N % 
Haematocrit (%) 2 5.8 6 15.0 32 80.0 
Haemoglogbin (g) 7 17.5 7 17.5 26 65.0 
Mean corpuscular volume 
(µ m3) 
15 37.5 24 60.0 1 2.5 
Mean corpuscular haemo-
globin  (pg/cell) 
17 42.5 20 50.0 3 7.5 
Mean corpuscular haemo-
globin concentration (g/dl) 
29 72.5 11 27.5 0 0.0 
Red cell distribution width 
(%) 





Red cell distribution width (%) Total 
Normal High 
N % of all 
patients 
N % of all 
patients 
N % of all 
patients 
Low 1 2.5 14 35.0 15 37.5 
Normal 7 17.5 17 42.5 24 60.0 
High 1 2.5 0 0.0 1 2.5 
Total 9 22.5 31 77.5 40 100.0 
   76 
Table 6 shows that 40.6% of patients who had a high
PCV were also iron deficient, using the criteria of Bess-
man et al4, whereas none of patients with PCVs within 
the normal range, were iron deficient.  
 
 
Table 6: Relationship between haematocrit level and 
presence of iron deficiency 






The subjects of this study were majorly patients with 
Fallot’s tetralogy, which is to be expected, being the 
most common CCHD. The apparent ‘under-
representation’ of TGA and TA, though indeed known 
to be much less common than Fallot’s tetralogy, maybe 
because some whose data were not complete were ex-
cluded from analysis. 
 
Children with CCHD often experience severe hypoxae-
mia which may cause damage to the organs, particularly; 
the lungs, kidneys, musculoskeletal system and the cen-
tral nervous system (CNS). A major compensatory 
mechanism to combat tissue hypoxaemia is secondary 
erythropoiesis with consequent increase in the red cell 
mass.5, 6 This study showed that 32 (80.0%) of the cases 
had high haematocrit values. Iron deficiency is repo ted 
to be common in individuals with CCHD even in the 
presence of high haematocrit levels.2,7, 8 These groups of 
children are often assumed not to be iron deficient be-
cause of the elevated red cell mass.  
 
The use of simple red cell indices has been shown t be 
effective in identifying iron deficiency in individuals 








N % N % N % 
Low 1 50.0 1 50.0 2 100.0 
Normal 6 100.0 0 0.0 6 100.0 
High 19 59.4 13 40.6 32 100.0 
Total 26 65.0 14 35.0 40 100.0 
haematocrit, haemoglobin concentration, MCV, MCHC 
and peripheral blood film examination are easy to per-
form, relatively inexpensive and are effective in identi-
fying iron deficiency when present.1, 9 These methods 
were employed in this study and in the absence of more 
expensive tests like serum transferrin and serum ferritin, 
14 (35%) of the 40 children with CCHD with iron defi-
ciency were identified.   
The prevalence obtained  in this study is similar to the 
37% prevalence reported by Kaemmerer, t al7 in 52 
German adults with CCHD. The figure is however much 
higher than the 16.9% quoted  in another report from 
Kenya among 112 children with CCHD.2  The findings 
in this study are therefore consistent with previous re-
ports showing that iron deficiency is a common feature 
in patients with CCHD. Notably, iron deficiency was 
present in 40.6% of children in the present study with 
high PCV levels but in none of the 6 patients whose 
PCVs were normal. This proportion is high enough for 
concern and might justify a practice of instituting judi-
cious iron therapy in patients with high PCVs , on the
assumption that deficiency is  likely to be present. 
CCHD is known to be associated with a reduction in 
oxygen delivery to the tissues. Iron deficiency in CCHD 
has been shown to be associated with a further reduction 
in oxygen delivery to the tissues.10 This further worsens 
the tissue hypoxaemia in individuals with CCHD. Clear 
recommendations for the supplementation of iron in 
children with CCHD are lacking. Our findings suggest 
that iron deficiency is common in Nigerian children with 
CCHD. Further studies using the gold-standard tests 
would still be required in order to verify the figures ob-
tained in this study. In the interim, it is recommend d 
that all children with CCHD should have routine assess-
ment of the simple haematological indices for prompt 
detection and judicious treatment of iron deficiency.  
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